摘要
目的观察p38丝裂原活化蛋白激酶(MAPK)抑制剂SB203580对LPS诱导的兔急性肺损伤(ALl)的保护作用及其机制。方法用大肠杆菌内毒素(LPS)制备兔ALI模型;测定不同时间点的动脉血气分析、血清TNF—α和ICAM-1浓度;测量肺干/湿质量比值(肺D/W)及观察肺组织病理学改变。结果动物注射内毒素1h后PA-aO2、血浆TNF—α和ICAM-1水平、肺损伤评分均明显升高(P〈0.05),肺D/W下降(P〈0.05);应用SB203580治疗后,PA-aO2、血浆TNF—α和ICAM-1水平、肺损伤评分均明显下降(P〈0.05),肺D/W升高(P〈0.05)。结论本研究结果表明,p38 MAPK抑制剂SB203580对内毒素诱导的ALI,可以明显减轻低氧血症、减轻肺水肿、改善组织病理学和减轻炎症反应。
Objective To evaluate the effects and mechanisms of p38 MAPK inhibitor on animal model of endotoxin - induced lung injury. Methods The rabbit ALl model was established by intravenous injection with LPS; blood gas analysis, serum tumor necrosis factor ot (TNF - α ) and intercellular adhesion molecule 1 ( ICAM - 1 ) levels were measured ; the ratio of dry weight and wet weight (D/W) of the lung was calculated, and lung histopathologic changes were observed. Results PA-aO2, serum TNF - α and ICAM - 1 levels, the lung injury score increased and lung D/W decreased after LPS injection( P 〈 0. 05 ). After the administration of p38 MAPK inhibitor, SB203580, PA -aO2, serum TNF - α and ICAM - 1 levels, the lung injury score decreased and lung D/W increased ( P 〈 0. 05). Conclusion The therapeutic effects of SB203580 on ALl in rabbits may be as: alleviating hypoxemia, lung edema and inflammatory reaction, and improving histopathology performance.
出处
《中国急救医学》
CAS
CSCD
北大核心
2010年第3期246-248,共3页
Chinese Journal of Critical Care Medicine